SOX9 and neoplasm: To test the effect of SOX9 depletion on OS tumor progression in vivo, we reduced the levels of SOX9 in SAOS2 cells using the two shRNAs and then transplanted cells into NOD-scid, IL2R gammanull (NSG) mice.